About Gene List

PF3D7_1216200

Genome location: Pf3D7_12_v3:647,969..650,704(+)

Genome classification: Core

Function and Localization

Product Description: glycerol-3-phosphate dehydrogenase [NAD(+)], putative

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 1.1.1.8 (Glycerol-3-phosphate dehydrogenase (NAD(+)));1.1.1.94 (Glycerol-3-phosphate dehydrogenase (NAD(P)(+)))

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005829 cytosol
Component GO:0009331 glycerol-3-phosphate dehydrogenase complex
Component GO:0005634 nucleus
Function GO:0004367 glycerol-3-phosphate dehydrogenase [NAD+] activity
Process GO:0006116 NADH oxidation
Process GO:0006072 glycerol-3-phosphate metabolic process

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite expressed N/A N/A
Ring expressed 0.35 0.84
Trophozoite expressed 0.39 0.77
Schizont expressed 0.19 0.89
Gametocyte expressed 0.19 0.88

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_1216200

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Non - Mutable in CDS

MIS: 0.135 | MFS: -3.106 | #Insertions: 0

PlasmoGEM Phenotype: Dispensable (Pb ortholog: PBANKA_1431900)

  • Relative Growth Rate: 0.85 ± 0.41
  • Confidence: 3.19

RMgmDB ABS Phenotype: Different from wild type (Pb ortholog: PBANKA_1431900)

Modification: Disrupted | RMgm-4300

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8I5P5

"Best" AlphaFill ligand hit: POP (pyrophosphate 2-, Local RMSD=0.47) with 6PYP (Global RMSD=2.29)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) ATPADPKClNAD+NADHNADPHSO42-ZnCl2FeCl2malateNADH-Xsuramin...
1.1.1.94 glycerol-3-phosphate dehydrogenase [NAD(P)+] ATPADPAMPKClNMNNAD+NADPHNADP+NH4ClK2SO4Na2SO4K2PO4-...

No evidence of orthology to BindingDB entries

Orthology Information

Ortholog Group (OrthoMCL): OG6_100385

Most Similar Human Ortholog: C9JFA7

TM-align score: 0.95 | RMSD: 1.23

Seq Identity: 0.41 | Length: 144 / 367

All Human Orthologs (OrthoMCL):

Gene ID Description
ENSG00000152642 glycerol-3-phosphate dehydrogenase 1 like
ENSG00000167588 glycerol-3-phosphate dehydrogenase 1

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 3 13 10 27
disruptive 7 18 8 22
missense 7 18 8 18

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 9 28 9 40
disruptive 14 39 20 67
missense 12 30 17 54

PlasmoDB Total SNPs: 201

Non-coding: 180 | Synonymous: 10 | Nonsynonymous: 11 | Stop Codon: 0

Protein Information

Protein Length: 367 | Molecular Weight (kDa): 41.234

UniProt ID(s): Q8I5P5

PDB ID(s): 1YJ8

Isoelectric Point: 7.27

Protein Domain Annotations:

Source Family ID Description
InterPro IPR006109 Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal
InterPro IPR006168 Glycerol-3-phosphate dehydrogenase, NAD-dependent
InterPro IPR008927 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
InterPro IPR011128 Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal
InterPro IPR017751 Glycerol-3-phosphate dehydrogenase, NAD-dependent, eukaryotic
InterPro IPR036291 NAD(P)-binding domain superfamily
PFam PF01210 Glycerol-3-phosphate dehydrogenase, NAD-dependent, N-terminal
PFam PF07479 Glycerol-3-phosphate dehydrogenase, NAD-dependent, C-terminal
Superfamily SSF48179 6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
Superfamily SSF51735 NAD(P)-binding domain superfamily

Associated Publications

PMID Title Authors DOI/Link
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
30379851 Identification of Plasmodium falciparum nuclear proteins by mass spectrometry andproposed protein annotation. Briquet S, Ourimi A, ..., Vaquero C 10.1371/journal.pone.0205596